Gene expression analyses using the ONCOMINE and the TIMER claimed that NAP1L1 mRNA levels were evidently higher in HCC than in non-tumor tissues (Figures 3G,H). The gene discussed is NAP1L1; the disease is hepatocellular carcinoma.